# OnCo record paper-intergroup-0099-chemoradiotherapy-nasopharyngeal-jco-1998 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-intergroup-0099-chemoradiotherapy-nasopharyngeal-jco-1998/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-intergroup-0099-chemoradiotherapy-nasopharyngeal-jco-1998" ;
  schema:name "Intergroup 0099: chemoradiotherapy versus radiotherapy in advanced nasopharyngeal cancer"@en ;
  schema:description "Adding cisplatin during radiotherapy and chemotherapy afterwards more than doubled the chance of being alive without disease three years later compared with radiotherapy alone, making chemoradiotherapy the standard for advanced nasopharyngeal cancer."@en ;
  schema:url <https://onco.cc/key-papers/paper-intergroup-0099-chemoradiotherapy-nasopharyngeal-jco-1998/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.1998.16.4.1310>, <https://pubmed.ncbi.nlm.nih.gov/9552031/> ;
  schema:sameAs <https://doi.org/10.1200/JCO.1998.16.4.1310> ;
  schema:datePublished "1998"^^xsd:gYear ;
  schema:author "Al-Sarraf M, LeBlanc M, Giri PG, et al." ;
  onco:cancers <https://onco.cc/cancers/locoregionally-advanced-nasopharyngeal-carcinoma/> ;
  onco:drugs <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/fluorouracil/> ;
  onco:journals <https://onco.cc/journals/jco/> .
